Joana Ferreira (JF) completed a MSc in Health Sciences (18/20) and a BSc in Biochemistry (17/20) at the University of Minho. During her MSc dissertation at the Life and Health Sciences Research Institute (ICVS), under the supervision of Dr. Céline S. Gonçalves and Dr. Bruno M. Costa, she studied the association between WNT6 expression and reduced glioblastoma sensitivity to the gold-standard chemotherapeutic temozolomide, aiming to uncover WNT6-driven molecular mechanisms underlying tumour aggressiveness and chemoresistance. Posteriorly, as a MSc fellowship researcher in the project Multi-Omic NETworks in Gliomas, she evaluated the biomarker potential of novel candidate molecules identified through prior bioinformatic analyses. Currently, she is a FCT-funded PhD student at the University of Minho, under the supervision of Dr. Céline S. Gonçalves, Dr. Bruno M. Costa, and Dr. Noel de Miranda. Her PhD project focuses on the interplay between glioblastoma and the immune system, with the goal of contributing to understand the spatial organization of glioblastoma, and explore how pharmacological targeting of oncogenic biomarkers can modulate immune activation and improve immunotherapy efficacy. Throughout her training, she has developed a multidisciplinary skill set encompassing in vitro molecular and functional assays, orthotopic and subcutaneous in vivo glioblastoma models, and bioinformatic analyses. She has participated in 11 national and international scientific meetings, contributing with 6 oral presentations (4 as co-first author) and 8 poster presentations (6 as co-first author). These communications have been recognised with 3 best oral presentation awards and 2 best poster presentation awards.